An NCI-designated Comprehensive Cancer Center

Carcinoid Tumors of the Lung

Less than 2 percent of lung cancers are carcinoids. There are about 4,000 newly diagnosed cases of lung carcinoid tumors in the United States each year, according to the American Cancer Society.

For patients confronted with lung carcinoid tumors, City of Hope offers care that is customized for each individual. Your treatment plan will be unique based on the characteristics of your disease and what quality of life means to you.

Our team of talented, compassionate surgeons, medical oncologists, radiopharmacists and experts in nuclear medicine — among many more — work together seamlessly. And the options are leading-edge, from our excellence in minimally invasive surgery to imaging technology that helps our oncologists pinpoint the best treatment plan for each patient.

Request an Appointment

If you have been diagnosed with lung carcinoids, you can make an appointment or seek a second opinion by requesting a consultation online or calling us at 800-826-HOPE. Please visit Making Your First Appointment for more information.

Our Expertise

Because carcinoid tumors of the lung are uncommon, it can be difficult to find the right help. City of Hope, located in Southern California, is a nationally recognized leader in the research and treatment of lung cancer and carcinoid tumors of the lung.

  • We have specialists who work regularly with patients facing neuroendocrine tumors, keep pace with the latest developments in treatment and push forward the state of the art with their own innovative research.
  • Our surgical expertise enables us to offer a wider array of options, including surgery for advanced disease and gentler robotic procedures.
  • City of Hope is designated as a comprehensive cancer center by the National Cancer Institute.
  • For more than a decade, U.S. News & World Report has named City of Hope one of the "Best Hospitals" for cancer in America.
  • We bring together a broad array of expertise from multiple specialties and are unmatched in our rapid “bench-to-bedside” record of translating leading-edge research into real-world treatments.

News & Breakthroughs


Help us turn innovative ideas into powerful new treatments
$ Other